Vote Scores

Home / Companies / Bio-Rad Laboratories, Inc. / 23 Apr 2024

Meeting · year to 30 June 2024234 filers reporting

Bio-Rad Laboratories, Inc.: meeting of 23 Apr 2024

Votes reported on Form N-PX, item by item

234 Form N-PX filers reported votes at the Bio-Rad Laboratories, Inc. meeting of 23 Apr 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 77.5% of reported votes for; 62 filers withheld from or voted against at least one nominee.

1,024 vote records from 226 filers. 42 of the 226 filers that marked the item either way voted against management.

77.4% for18.6% against4.0% other18.6% against management226 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

5 vote records from 5 filers. 0 of the 5 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management5 filers100.0% for0.0% against0.0% against management527 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

510 vote records from 225 filers. 2 of the 225 filers that marked the item either way voted against management.

99.1% for0.4% against0.4% other0.9% against management225 filers99.9% for0.1% against0.0% other0.1% against management6,358,836 reported shares
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

512 vote records from 227 filers. 8 of the 227 filers that marked the item either way voted against management.

96.5% for3.1% against0.4% other3.5% against management227 filers99.7% for0.3% against0.0% other0.3% against management6,380,585 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors3. Auditor
VanguardForFor
BlackRock and iSharesForFor
FidelityForFor
DimensionalSplit or no voteFor
State Street and SPDRForFor
American CenturyForFor
Franklin TempletonAgainst *For
InvescoForFor
EquitableAgainst *For
Charles SchwabAgainst *For
Nuveen and TIAAForFor
ProShares and ProFundsForFor
John Hancock and ManulifeForFor
Morgan Stanley, Eaton Vance and CalvertAgainst *For
J.P. MorganForFor
Goldman SachsForFor
WisdomTreeForFor
PGIM and PrudentialForFor
Jackson National fundsForFor
Northern Trust and FlexSharesForFor
SEIAgainst *For
T. Rowe PriceAgainst *For
ThriventForFor
Lincoln FinancialForFor
VoyaAgainst *For
First TrustForFor
NationwideForFor
Victory CapitalForFor
Brighthouse FundsForFor
Guggenheim and RydexForFor
Columbia ThreadneedleForFor
BNY MellonForFor
PrincipalForFor
Pacific Life fundsForFor
Global XAgainst *For
MFSForFor
TransamericaForFor
Federated HermesSplit or no voteFor
AllianceBernsteinAgainst *For
Hartford FundsAgainst *For
DWSForFor
AllspringForFor
MassMutualForFor
Harbor FundsForFor
VirtusForFor
Natixis and Loomis SaylesForFor
Artisan PartnersForFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Bio-Rad Laboratories, Inc. meeting?

234 Form N-PX filers reported votes at the meeting of 23 Apr 2024. On say-on-pay, 0 of 5 voted against management (0.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Bio-Rad Laboratories, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Bio-Rad Laboratories, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Bio-Rad Laboratories, Inc. with a meeting date within three days of 23 Apr 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.